Validation of a computed tomography diagnostic model for differentiating fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis
- PMID: 38996781
- DOI: 10.1016/j.resinv.2024.07.002
Validation of a computed tomography diagnostic model for differentiating fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis
Abstract
Background: The diagnosis of fibrotic hypersensitivity pneumonitis (fHP) from other interstitial lung diseases, particularly idiopathic pulmonary fibrosis (IPF), is often difficult. This study aimed to examine computed tomography (CT) findings that were useful for differentiating between fHP and IPF and to develop and validate a radiological diagnostic model.
Methods: In this study, 246 patients (fHP, n = 104; IPF, n = 142) from two institutions were included and randomly divided into the test (n = 164) and validation (n = 82) groups (at a 2:1 ratio). Three radiologists evaluated CT findings, such as pulmonary fibrosis, small airway disease, and predominant distribution, and compared them between fHP and IPF using binomial logistic regression and multivariate analysis. A prognostic model was developed from the test group and validated with the validation group.
Results: Ground-glass opacity (GGO) with traction bronchiectasis (TB), honeycombing, hypoattenuation area, three-density pattern, diffuse craniocaudal distribution, peribronchovascular opacities in the upper lung, and random distribution were more common in fHP than in IPF. In multivariate analysis, GGO with TB, peribronchovascular opacities in the upper lung, and random distribution were significant features. The area under the curve of the fHP diagnostic model with the three aforementioned CT features was 0.733 (95% confidence interval [CI], 0.655-0.811, p < 0.001) in the test group and 0.630 (95% CI, 0.504-0.755, p < 0.047) in the validation group.
Conclusion: GGO with TB, peribronchovascular opacities in the upper lung, and random distribution were important CT features for differentiating fHP from IPF.
Keywords: CT; Diagnostic model; Fibrotic hypersensitivity pneumonitis; Idiopathic pulmonary fibrosis.
Copyright © 2024 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest KK received lectures fees from Boehringer Ingelheim. YK received lectures fees from Boehringer Ingelheim. YM received grants from Boehringer Ingelheim, and lectures fees from Boehringer Ingelheim and AstraZeneca. TJ received lectures fees from Bohlinger Ingelheim, AstraZeneca, and Kyorin Inc. The other authors have no conflicts of interest.
Similar articles
-
The new useful high-resolution computed tomography finding for diagnosing fibrotic hypersensitivity pneumonitis: "hexagonal pattern": a single-center retrospective study.BMC Pulm Med. 2022 Mar 4;22(1):76. doi: 10.1186/s12890-022-01869-4. BMC Pulm Med. 2022. PMID: 35246090 Free PMC article.
-
Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis.Eur Respir J. 2019 Jul 25;54(1):1900531. doi: 10.1183/13993003.00531-2019. Print 2019 Jul. Eur Respir J. 2019. PMID: 31164428
-
[Comparative pathomorphological characteristics of idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis].Arkh Patol. 2022;84(1):59-66. doi: 10.17116/patol20228401159. Arkh Patol. 2022. PMID: 35166480 Russian.
-
Pathologic Criteria for the Diagnosis of Usual Interstitial Pneumonia vs Fibrotic Hypersensitivity Pneumonitis in Transbronchial Cryobiopsies.Mod Pathol. 2023 Sep;36(9):100221. doi: 10.1016/j.modpat.2023.100221. Epub 2023 May 24. Mod Pathol. 2023. PMID: 37236510 Review.
-
Integration and Application of Clinical Practice Guidelines for the Diagnosis of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis.Chest. 2022 Sep;162(3):614-629. doi: 10.1016/j.chest.2022.06.013. Epub 2022 Jun 20. Chest. 2022. PMID: 35738345 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical